AASLD-INASL Joint Webinar: Advances in MASH Diagnosis and Treatment World MASH Day 2026

Date : Thursday, June 11, 11:00 am - 12:00 pm (EDT)

Moderators: Christina Awad, MD; Shivaram P Singh, DM, FACG, AGAF, FRCP [Edin]., FAASLD 
Presenters: Shalimar, DM; Rohit Loomba, MD, MHSc, FAASLD; Arka De, MD, DM 

AASLD and INASL are excited to present their annual joint global webinar. This year's theme is on MASLD/MASH, where experts will discuss the evolving MASH diagnostic landscape and outline integrated management strategies for cardiometabolic comorbidities in MASH patients. 

This webinar is ideal for: 
• Hepatologists
• Gastroenterologists
• Hepatology Associates
• Industry Partners
• Advanced Practitioners

Upon completion of this activity, participants should be able to: 
     • Describe the evolving diagnostic landscape for MASH, including the implementation of non-invasive testing strategies. 
     • Review the latest FDA-approved and emerging pharmacological therapies for MASH, focusing on the 2024-2025 approvals of resmetirom 
and semaglutide. 
     • Discuss the integrated management of cardiometabolic comorbidities in MASH patients, including the role of incretin-based therapies (GLP-1 and dual agonists), cardiovascular risk reduction strategies, and hepatocellular carcinoma surveillance recommendations.